Wilmington Savings Fund Society FSB Makes New $100,000 Investment in Waters Co. (NYSE:WAT)

Wilmington Savings Fund Society FSB purchased a new stake in Waters Co. (NYSE:WAT) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 279 shares of the medical instruments supplier’s stock, valued at approximately $100,000.

Other institutional investors also recently modified their holdings of the company. Summit Trail Advisors LLC grew its position in Waters by 2.4% in the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock valued at $431,000 after acquiring an additional 28 shares during the last quarter. OneDigital Investment Advisors LLC grew its holdings in shares of Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 31 shares during the last quarter. Raymond James Trust N.A. increased its position in Waters by 2.4% during the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock worth $482,000 after purchasing an additional 32 shares in the last quarter. Linscomb Wealth Inc. lifted its stake in Waters by 0.4% in the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock valued at $2,275,000 after purchasing an additional 34 shares during the last quarter. Finally, Johnson Investment Counsel Inc. boosted its position in Waters by 3.2% in the second quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock valued at $314,000 after buying an additional 34 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 2.1 %

Shares of NYSE WAT opened at $368.16 on Friday. Waters Co. has a 52-week low of $279.24 and a 52-week high of $397.02. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The company’s 50 day moving average price is $367.05 and its 200-day moving average price is $337.42. The company has a market capitalization of $21.86 billion, a P/E ratio of 35.13, a price-to-earnings-growth ratio of 6.92 and a beta of 1.01.

Waters (NYSE:WAT) last issued its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. During the same quarter in the prior year, the firm posted $2.84 earnings per share. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities analysts forecast that Waters Co. will post 11.79 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently issued reports on WAT. TD Cowen upped their price target on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Barclays upped their target price on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a report on Monday, November 4th. Sanford C. Bernstein lifted their price target on Waters from $345.00 to $360.00 and gave the company a “market perform” rating in a research note on Monday, November 4th. Wells Fargo & Company boosted their price target on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus raised their price objective on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $375.85.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.